Company Name, Ticker, Customers, else..

Mersana Therapeutics inc (NASDAQ: MRSN)

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Mersana Therapeutics Inc 's

Name: Mersana Therapeutics Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MRSN Sales vs. its Competitors Q3 2025

Comparing the current results to its competitors, Mersana Therapeutics Inc reported Revenue decrease in the 3 quarter 2025 year on year by -12.61 %, despite the revenue increase by the most of its competitors of 76.42 %, recorded in the same quarter.

• List of MRSN Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Mersana Therapeutics inc recorded a net loss, as well as most of its competitors.

<< MRSN Stock Performance Comparisons

<< See the full list of MRSN competitors

Overall company Market Share Q3 2025

Overall company, revenue fell by -12.61 % and company lost market share, to approximately 1.51 %. << More on MRSN Market Share.

*Market share is calculated based on total revenue.

News about Mersana Therapeutics inc Contracts

Mersana Therapeutics Surges Ahead with Exciting Business Updates, 2024 Milestones, and Participation in Prestigious Healthcare Conference

January 5, 2024
Mersana Therapeutics, a renowned clinical-stage biopharmaceutical company, recently released some crucial business updates along with their anticipated milestones for the year 2024. Additionally, the company has announced its participation in the upcoming 42nd Annual J.P. Morgan Healthcare Conference, where they will be presenting their latest advancements in the field of antibody-drug conjugates (ADCs) targeting various cancers with high unmet medical needs.Based in Cambridge, Massachusetts, Mersana Therapeutics is dedicated to discovering and developing an extensive pipeline of ADCs. These drugs are designed to combine the specificity of monoclonal antibodies with the potency of various toxins to specifica...

MRSN's Stock Performance relative to its Competitors

Publicly Traded Peers of Mersana Therapeutics inc

Mira Pharmaceuticals Inc
Share Performance

-24.38%

This Quarter

Mira Pharmaceuticals Inc

Profile

Mira Pharmaceuticals Inc's business model is focused on the development and sale of pharmaceutical products, with a particular emphasis on research and innovation in the healthcare industry.

More about Mira Pharmaceuticals Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 32.096 mill.	$ - mill.	$ -9.480 mill.

Milestone Pharmaceuticals Inc
Share Performance

-6.25%

This Quarter

Milestone Pharmaceuticals Inc

Profile

Milestone Pharmaceuticals Inc. is a pharmaceutical company that focuses on developing and commercializing innovative therapies for cardiovascular diseases. Their business model revolves around identifying unmet medical needs in the cardiovascular space and leveraging their expertise in drug development to create novel treatments. By conducting rigorous research, clinical trials, and collaborations, Milestone Pharmaceuticals aims to bring effective and safe medications to market, positively impacting patients' lives.

More about Milestone Pharmaceuticals Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 149.398 mill.	$ 2.343 mill.	$ -84.011 mill.

Novabridge Biosciences
Share Performance

-2.17%

Over The Past 5 Days

Novabridge Biosciences

Profile

The company develops drug candidates and conducts related research and development activities in China.

More about Novabridge Biosciences's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 172.377 mill.	$ - mill.	$ -88.340 mill.

Nucana Plc
Share Performance

-20.45%

Over The Past 5 Days

Nucana Plc

Profile

Nucana Plc is a pharmaceutical company that focuses on developing novel treatments for cancer and other diseases.

More about Nucana Plc's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ - mill.	$ - mill.	$ -61.553 mill.

Nurix Therapeutics Inc
Share Performance

-0.27%

Over The Past 5 Days

Nurix Therapeutics Inc

Profile

Nurix Therapeutics Inc's business model involves developing targeted protein degradation therapies to treat diseases by modulating the body's cellular protein levels.

More about Nurix Therapeutics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 2,903.747 mill.	$ 36.766 mill.	$ -341.351 mill.

56 more competitors available

Sources: Mersana Therapeutics inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Sunday, September 6, 2026 6:18 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Mersana Therapeutics inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.